Home Astra Signals A Late Run On BTK Inhibition
 

Keywords :   


Astra Signals A Late Run On BTK Inhibition

2015-12-14 19:08:14| Biotech - Topix.net

This morning's confirmation that AstraZeneca had made an approach to Acerta Pharma casts the spotlight on what is a private biotech that has quietly positioned itself as the most advanced developer of a BTK inhibitor after AbbVie 's blockbuster Imbruvica . Have you spotted the link? AbbVie had acquired Imbruvica through a $21bn takeover of Pharmacyclics , and Acerta was founded by Ahmed Hamdy- none other than Pharmacyclics ' ex-chief medical officer.

Tags: run late signals inhibition

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11contactglove tundratracker
23.11
23.11RUSSELUNO
23.11C282 800yd IP54
23.11X-FLY4 27.5
23.118
23.11 (1~40)
23.1101DVDBOX
More »